Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types
- PMID: 27364892
- PMCID: PMC4973317
- DOI: 10.1038/emm.2016.64
Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types
Abstract
Granulocyte-macrophage colony-stimulating factor (GM-CSF, also called CSF-2) is best known for its critical role in immune modulation and hematopoiesis. A large body of experimental evidence indicates that GM-CSF, which is frequently upregulated in multiple types of human cancers, effectively marks cancer cells with a 'danger flag' for the immune system. In this context, most studies have focused on its function as an immunomodulator, namely its ability to stimulate dendritic cell (DC) maturation and monocyte/macrophage activity. However, recent studies have suggested that GM-CSF also promotes immune-independent tumor progression by supporting tumor microenvironments and stimulating tumor growth and metastasis. Although some studies have suggested that GM-CSF has inhibitory effects on tumor growth and metastasis, an even greater number of studies show that GM-CSF exerts stimulatory effects on tumor progression. In this review, we summarize a number of findings to provide the currently available information regarding the anticancer immune response of GM-CSG. We then discuss the potential roles of GM-CSF in the progression of multiple types of cancer to provide insights into some of the complexities of its clinical applications.
Figures
Similar articles
-
A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease.Ann Surg Oncol. 2007 Feb;14(2):869-84. doi: 10.1245/s10434-006-9196-4. Epub 2006 Nov 14. Ann Surg Oncol. 2007. PMID: 17103257 Clinical Trial.
-
Recent progress in GM-CSF-based cancer immunotherapy.Immunotherapy. 2017 Mar;9(4):347-360. doi: 10.2217/imt-2016-0141. Immunotherapy. 2017. PMID: 28303764 Review.
-
The regulation of the development and function of dendritic cell subsets by GM-CSF: more than a hematopoietic growth factor.Mol Immunol. 2012 Aug;52(1):30-7. doi: 10.1016/j.molimm.2012.04.009. Epub 2012 May 14. Mol Immunol. 2012. PMID: 22580403 Review.
-
Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients.J Immunol. 2011 Dec 1;187(11):6130-42. doi: 10.4049/jimmunol.1102209. Epub 2011 Nov 2. J Immunol. 2011. PMID: 22048768 Clinical Trial.
-
Dendritic cells: emerging roles in tumor immunotherapy.Clin J Oncol Nurs. 2006 Oct;10(5):629-40. doi: 10.1188/06.CJON.629-640. Clin J Oncol Nurs. 2006. PMID: 17063617 Review.
Cited by
-
Evaluation of the Effects of Genistein In Vitro as a Chemopreventive Agent for Colorectal Cancer-Strategy to Improve Its Efficiency When Administered Orally.Molecules. 2022 Oct 19;27(20):7042. doi: 10.3390/molecules27207042. Molecules. 2022. PMID: 36296636 Free PMC article.
-
Insights Into Mechanisms of Tumor and Immune System Interaction: Association With Wound Healing.Front Oncol. 2019 Oct 25;9:1115. doi: 10.3389/fonc.2019.01115. eCollection 2019. Front Oncol. 2019. PMID: 31709183 Free PMC article.
-
Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathway.Oncol Rep. 2022 Jul;48(1):122. doi: 10.3892/or.2022.8333. Epub 2022 May 18. Oncol Rep. 2022. PMID: 35583004 Free PMC article.
-
Harnessing cancer immunotherapy during the unexploited immediate perioperative period.Nat Rev Clin Oncol. 2020 May;17(5):313-326. doi: 10.1038/s41571-019-0319-9. Epub 2020 Feb 17. Nat Rev Clin Oncol. 2020. PMID: 32066936 Review.
-
Immune-related LncRNAs scores predicts chemotherapeutic responses and prognosis in cervical cancer patients.Discov Oncol. 2024 Apr 14;15(1):119. doi: 10.1007/s12672-024-00979-1. Discov Oncol. 2024. PMID: 38615287 Free PMC article.
References
-
- van de Laar L, Coffer PJ, Woltman AM. Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy. Blood 2012; 119: 3383–3393. - PubMed
-
- Ohashi K, Kobayashi G, Fang S, Zhu X, Antonia SJ, Krieg AM et al. Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma. J Pediatr Surg 2006; 41: 1361–1368. - PubMed
-
- Barreda DR, Hanington PC, Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 2004; 28: 509–554. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources